3181 results for «3154»
3181 results
Procedural imaging for tricuspid valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
Focused on procedural imaging for tricuspid valve interventions, this session covers essential anatomical and pathophysiological insights necessary for successful transcatheter approaches. It details TEE and ICE imaging techniques including live 3D-MPR, and provides a systematic framework for assessing procedural outcomes and device positioning through interactive case...
Mitral TEER: LIVE Educational Case from Nagoya Heart Center - Nagoya, Japan
15 Feb 2026 – From PCR Tokyo Valves 2026
This session delivers an in-depth exploration of mitral Transcatheter Edge-to-Edge Repair (TEER) featuring a live educational case from Nagoya Heart Center, Japan. It emphasizes the contemporary procedural steps, the pivotal role of advanced imaging in transcatheter mitral interventions, and discusses the spectrum of transcatheter options available...
Future devices and techniques for structural heart disease
15 Feb 2026 – From PCR Tokyo Valves 2026
Explore the future landscape of structural heart disease treatment by examining current limitations of transcatheter valvular technologies. This session discusses emerging devices and innovative techniques for aortic, mitral, and tricuspid valve interventions, providing a forward-looking perspective on therapeutic advancements.
Guidelines update
15 Feb 2026 – From PCR Tokyo Valves 2026
Review the latest updates to the ESC/EACTS guidelines with a focus on their impact for managing structural heart disease. Key topics include new age cutoffs and asymptomatic disease management in aortic valve interventions, revised mitral valve recommendations, integration of tricuspid TEER and TTVR, and clinical implications...
Newly emerging devices from Asia and upcoming trials on new TAVI frontier
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights newly emerging transcatheter aortic valve implantation (TAVI) devices from Asia and presents ongoing and upcoming clinical trials exploring innovative TAVI frontiers. It provides insights into the evolving device landscape and evidence shaping future directions in TAVI therapy.
All you need to know about redo TAVI
15 Feb 2026 – From PCR Tokyo Valves 2026
This comprehensive session addresses the complexities of redo Transcatheter Aortic Valve Implantation (TAVI). It covers the full spectrum from pre-procedural analysis—including coronary obstruction risk and valve sizing—to procedural strategies like leaflet modification and optimal positioning. Post-procedural management including antithrombotic therapy and patient-prosthesis mismatch are also examined,...
Team approach to structural heart disease: how to handle unexpected situations
14 Feb 2026 – From PCR Tokyo Valves 2026
This session emphasizes the importance of a multidisciplinary team approach in managing unexpected events during structural heart disease interventions. Through real-world examples, it highlights the roles and responses of radiologic technologists, clinical engineers, sonographers, and nursing staff in effectively addressing intraoperative complications and postoperative challenges to...
Procedural optimisation for enhanced acute and long-term outcomes
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into procedural optimization techniques for transcatheter aortic valve implantation (TAVI) to enhance both acute and long-term outcomes. It discusses critical procedural factors such as valve sizing, expansion, implantation depth, and commissural alignment, and their role in valve durability and survival. Practical cathlab cases...
Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System
14 Feb 2026 – From PCR Tokyo Valves 2026
Examine the critical role of cerebral protection during TAVI with a focus on the SENTINEL Cerebral Protection System. This session reviews adoption trends in the United States and Japan, clinical outcomes at one year post-implementation in Japan, and a detailed analysis of clinical trials including a...
Patient selection for tricuspid TEER in 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delineates criteria for optimal patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. Integrating anatomical, haemodynamic, and clinical parameters, it clarifies the evolving indications relative to transcatheter tricuspid valve replacement (TTVR) and conservative management. Real-world cases informed by pivotal trials such as TRILUMINATE,...
Built to last: lifetime management for durability and beyond
14 Feb 2026 – From PCR Tokyo Valves 2026
Focused on lifetime management, this session addresses practical considerations for maximizing durability and long-term outcomes in complex valve cases. Topics include the significance of initial valve choice, techniques to optimize paravalvular leak management, and strategies for successful redo TAVI procedures, supported by clinical examples and expert...
Getting ready for tricuspid TEER: key steps in building a successful programme
14 Feb 2026 – From PCR Tokyo Valves 2026
Prepare to build a successful tricuspid TEER program with systematic approaches to patient selection, echocardiographic assessment, and procedural fundamentals. This session includes case demonstrations and reviews recent clinical evidence to support program development.
Miscellaneous complications: my worst nightmare
15 Feb 2026 – From PCR Tokyo Valves 2026
Address complications arising from transcatheter interventions in structural heart disease by discussing real-case scenarios and strategies for prevention and management. This session presents challenging cases across TAVI, mitral, and tricuspid interventions to enhance clinical preparedness and patient safety.
Transcatheter valve-in-valve intervention: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia
14 Feb 2026 – From PCR Tokyo Valves 2026
Experience a live educational case on transcatheter valve-in-valve intervention highlighting anatomical challenges, the critical role of pre-procedural CT imaging, and meticulous planning to prevent life-threatening complications and achieve favorable long-term outcomes.
Mastering mitral TEER: guidelines, complex cases, and Asia Pacific insights
14 Feb 2026 – From PCR Tokyo Valves 2026
This session provides an in-depth analysis of mitral transcatheter edge-to-edge repair (TEER) in light of the 2025 ESC Valvular Heart Disease guidelines. It addresses optimal timing and treatment strategies for severe heart failure beyond established trials, and explores technical solutions for complex anatomies. Special attention is...
Mastering techniques from basic to complex - Tips and tricks for advanced mitral TEER: anatomy and imaging
13 Feb 2026 – From PCR Tokyo Valves 2026
This session offers advanced insights into mitral TEER, emphasizing anatomical understanding and imaging to improve clinical outcomes. It also addresses device function, procedural steps, and management of common complications to refine interventional skills.
Real world outcomes and strategies for optimal TEER across diverse DMR anatomies
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into the real-world complexities of degenerative mitral regurgitation (DMR) and presents advanced strategies for transcatheter edge-to-edge repair (TEER) using the PASCAL device. Participants will explore the latest registry data, device selection criteria, and tactical approaches to manage diverse and challenging DMR anatomies, aiming...
Mastering techniques from basic to complex - Tricuspid TEER fundamentals
13 Feb 2026 – From PCR Tokyo Valves 2026
Gain foundational knowledge in tricuspid TEER, covering anatomical criteria for patient suitability, key procedural steps, and advanced device techniques. The session includes practical insights using a beating heart simulator to enhance procedural expertise.
Mastering LAA closure: a step-by-step case experience
14 Feb 2026 – From PCR Tokyo Valves 2026
This session presents a step-by-step, case-based approach to mastering left atrial appendage (LAA) closure. It covers pre-procedural planning, device-specific strategies, complication prevention, and complex bailout techniques such as leak closure with coiling or dual-device implantation.
Patient-tailored treatment for bicuspid valve
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on patient-tailored treatment for bicuspid aortic valve stenosis, providing comprehensive insights into the evidence base for TAVI in this population. It discusses critical considerations for valve selection and sizing, and highlights anatomical features that may pose challenges for TAVI procedures. Case studies illustrate...